Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 2
|
pp. 1484–1495
LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration
Back to article
Figure 8
(8 of 8)
−
100%
+
Figure 8.
Correlation between LRP6 expression and drug sensitivity.
Spearman correlation analysis of sunitinib, sorafenib, pazopanib, axtinib and erlotinib IC50 score and LRP6 expression.